Dietary Antioxidants and Thiol Disulfide Homeostasis in T2DM

Sponsor
Ankara Yildirim Beyazıt University (Other)
Overall Status
Completed
CT.gov ID
NCT05688631
Collaborator
Baskent University (Other)
87
1
3.5
24.7

Study Details

Study Description

Brief Summary

This observational study was planned to determine the relationship between dietary antioxidant intake and thiol disulfide homeostasis of individuals with type 2 diabetes. One of the current approaches in medical nutrition therapy of diabetes is to increase the consumption of foods with high antioxidant content in order to strengthen antioxidant defense. Increased dietary antioxidant intake may have both protective and therapeutic effects by reducing the risk of diabetes and preventing complications that may occur. It is known that dynamic thiol disulfide balance can be a good indicator of antioxidant defense in individuals with diabetes, and there are limited studies on this subject.

Condition or Disease Intervention/Treatment Phase
  • Other: Dietary antioxidant intake

Detailed Description

Power analysis was performed to determine the study sample. In order to reveal a moderate to high level effect for each parameter with 80% power and 5% margin of error, it was found appropriate to work with a total of 68 people, 34 of whom were T2DM and 34 of whom were healthy. In order to keep the sample size higher, a total of 87 individuals, including 40 T2DM and 47 healthy individuals, were included in this study. Individuals who agreed to participate in the study gave their informed consent. Anthropometic measurements (body weight and height) were taken by the researcher. BMI values of individuals were calculated with the formula of body weight (kg)/height (m)2 Routine fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, very low-density lipoprotein (VLDL), non-HDL cholesterol, Total/HDL cholesterol ratio, triglyceride (TG), C-reactive protein (CRP) values were analyzed with blood samples taken by the nurse on an 8 hours of fasting in the morning. Dynamic thiol disulfide balance was determined by native thiol, total thiol and disulfide values and oxidized albumin was determined by IMA values. Food consumption records of individuals were taken to determine dietary antioxidant intake and dietary antioxidant capacity. Oxidative balance score was used to evaluate the exposure of individuals to antioxidants and prooxidants. Descriptive statistics for categorical variables are presented as frequency and percentage. The conformity of the numerical variables to the normal distribution was checked using the Shapiro-Wilk Test. The descriptive statistics of numerical variables were given as mean (±) standard deviation for those with normal distribution, and median interquartile range [IQR] values for those without normal distribution. In the comparison of two independent groups; Independent Sample T Test was used if the data provided the assumptions of the parametric tests, the Mann-Whitney U Test was used if the assumptions of the parametric tests were not met, and the Chi-square Test was used for the comparison of two qualitative groups. Examination of the relationships between quantitative variables was determined by the "Pearson Correlation Coefficient" for those with normal distribution and the Spearman Correlation Coefficient for those who did not. In the interpretation of the correlation coefficient, very weak correlation criteria were used if <0.2, weak correlation between 0.2-0.4, moderate correlation between 0.4-0.6, high correlation between 0.6-0.8, and very high correlation if 0.8>. Statistical significance level was considered as α<0.05, α<0.01, α<0.001 in all calculations and interpretations and hypotheses were established as bidirectional. Statistical analysis of the data was performed with SPSS v26 (IBM Inc., Chicago, IL, USA) statistical package program.

Study Design

Study Type:
Observational
Actual Enrollment :
87 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Dietary Antioxidant Intake and Thiol Disulfide Homeostasis Relationship in Type 2 Diabetes Mellitus
Actual Study Start Date :
Jan 3, 2021
Actual Primary Completion Date :
Mar 12, 2021
Actual Study Completion Date :
Apr 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Diabetic participants (case group)

Participants diagnosed with type 2 diabetes mellitus

Other: Dietary antioxidant intake
Decreased intake of dietary antioxidant is associated with decreased thiol disulfide homeostasis parameters in diabetic and healthy participants.

Healthy participants (control group)

Participants not diagnosed with type 2 diabetes mellitus or any other chronic diseases

Other: Dietary antioxidant intake
Decreased intake of dietary antioxidant is associated with decreased thiol disulfide homeostasis parameters in diabetic and healthy participants.

Outcome Measures

Primary Outcome Measures

  1. Serum native thiol level [Baseline (preprandial in the morning)]

    serum native thiol level in μmol/L

  2. Serum disulphide level [Baseline (preprandial in the morning)]

    serum disulphide level in μmol/L

  3. Serum total thiol level [Baseline (preprandial in the morning)]

    serum total thiol level in μmol/L

  4. Disulphide/native thiol ratio [Baseline (preprandial in the morning)]

    Disulphide/native thiol ratio X (100 )

  5. Disulphide/total thiol ratio [Baseline (preprandial in the morning)]

    Disulphide/total thiol ratio X (100 )

  6. Native thiol/total thiol ratio [Baseline (preprandial in the morning)]

    Native thiol/total thiol ratio X (100 )

  7. Dietary antioxidant capacity [Baseline]

    Dietary intake assessed using 3-day dietary records. Participants instructed to record all dietary intake for 3 consecutive days, including 2 weekdays and 1 weekend day. Average value of 3 day nutrients were recorded and analyzed using Nutrition Data Base Ebispro for Windows, Stuttgart, Germany; Turkish Version (BeBiS 8.2), for Research software.

Secondary Outcome Measures

  1. Ischemia-modified albumin [Baseline (preprandial in the morning)]

    ischaemia-modified albumin in ABSU

  2. Dietary antioxidant intake [Baseline]

    Dietary intake assessed using 3-day dietary records. Participants instructed to record all dietary intake for 3 consecutive days, including 2 weekdays and 1 weekend day. Average value of 3 day nutrients were recorded and analyzed using Nutrition Data Base Ebispro for Windows, Stuttgart, Germany; Turkish Version (BeBiS 8.2), for Research software.

  3. Oxidative balance score [Baseline]

    Dietary intake assessed using 3-day dietary records. Participants instructed to record all dietary intake for 3 consecutive days, including 2 weekdays and 1 weekend day. Average value of 3 day nutrients were recorded and analyzed using Nutrition Data Base Ebispro for Windows, Stuttgart, Germany; Turkish Version (BeBiS 8.2), for Research software.

  4. Fasting plasma glucose [Baseline (preprandial in the morning)]

    Fasting plasma glucose in mg/dL

  5. hemoglobin A1c (HbA1c) [Baseline (preprandial in the morning)]

    hemoglobin A1c (HbA1c) in %

  6. Total cholesterol [Baseline (preprandial in the morning)]

    Total cholesterol in mg/dL

  7. Low-density lipoprotein (LDL) cholesterol [Baseline (preprandial in the morning)]

    Low-density lipoprotein (LDL) cholesterol in mg/dL

  8. High-density lipoprotein (HDL) cholesterol [Baseline (preprandial in the morning)]

    High-density lipoprotein (HDL) cholesterol in mg/dL

  9. Very low-density lipoprotein (VLDL) cholesterol [Baseline (preprandial in the morning)]

    Very low-density lipoprotein (VLDL) cholesterol in mg/dL

  10. non high-density lipoprotein (HDL) cholesterol [Baseline (preprandial in the morning)]

    non high-density lipoprotein (HDL) cholesterol in mg/dL

  11. total/high-density lipoprotein (HDL) cholesterol [Baseline (preprandial in the morning)]

    total/high-density lipoprotein (HDL) cholesterol ratio

  12. Triglyceride [Baseline (preprandial in the morning)]

    Triglyceride in mg/dL

  13. C-reactive protein [Baseline (preprandial in the morning)]

    C-reactive protein in mg/dL

  14. Body weight [Baseline]

    Body weight in kg

  15. Height [Baseline]

    Height in meters

  16. Body mass index [Baseline]

    Body weight was measured via bioelectrical impedance analysis. Body height was taken by trained researcher in Frankfort Plane via Stadiometer. Weight and height combined to report body mass index in kg/m^2.

  17. Fat mass [Baseline]

    Fat mass in kg

  18. Fat mass percentage [Baseline]

    Fat mass percentage in %

  19. Fat free mass [Baseline]

    Fat free mass in kg

  20. Total body water [Baseline]

    Total body water in kg

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria (for case group):
  • Diagnosis with type 2 diabetes mellitus

  • Diabetes age for a maximum of 5 years

  • Body mass index (BMI)<30 kg/m^2

  • Received and applied medical nutrition therapy and metformin therapy

Inclusion Criteria (for control group):
  • Body mass index (BMI) <30 kg/m^2
Exclusion Criteria (for case group):
  • Receiving insulin therapy

  • Developing diabetes-specific complications

  • Smoking tobacco

  • Consuming alcohol

  • Having end-stage chronic renal failure

  • Receiving chemotherapy and/or radiotherapy

  • Being in menopause, pregnant and/or lactation period

  • Using antioxidant vitamin and mineral supplements

Exclusion Criteria (for control group):
  • Smoking tobacco

  • Using alcohol

  • Having any chronic disease

  • Having end-stage chronic renal failure

  • Receiving chemotherapy and/or radiotherapy

  • Being in menopausal, pregnant and/or lactation period,

  • Using antioxidant vitamin and mineral supplements

  • Following any diet program

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara Yıldırım Beyazıt University Ankara Turkey

Sponsors and Collaborators

  • Ankara Yildirim Beyazıt University
  • Baskent University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rahime Evra KARAKAYA, Principal Investigator, Ankara Yildirim Beyazıt University
ClinicalTrials.gov Identifier:
NCT05688631
Other Study ID Numbers:
  • AnkaraYBU-KARAKAYA001
First Posted:
Jan 18, 2023
Last Update Posted:
Jan 18, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rahime Evra KARAKAYA, Principal Investigator, Ankara Yildirim Beyazıt University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2023